EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Immune-Chemokine Axis in Alzheimer’s Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression

José Joaquín Merino, José Julio Rodríguez-Arellano, Xavier Busquets iD, Isabel Álvarez-Vicente iD, María Eugenia Cabaña-Muñoz, Ana Isabel Flores iD, Adolfo Toledano Gasca iD

Biomolecules · 2026

DOI: 10.3390/biom16060855 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von José Joaquín Merino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Farmacia, Departamento de Farmacología, Farmacognosia y Botánica, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Adaptive Immunity, Chemokines, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Ramon and Cajal Research Program”, Spanish Ministry of Science, Innovation and Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by amyloid-β (Aβ) and the accumulation of tau in the brain, which triggers robust innate immune responses. Growing evidence indicates that neuroinflammation contributes to AD progression by overactivating microglia through the release of cytokines and chemokines. In general, chemokines can disrupt neuronal communication and promote blood–brain barrier permeability. Peripheral immune cells are mobilized into the brain by a gradient of chemokines. These processes link peripheral immune responses with substantial T-cell infiltration into the CNS parenchyma, leptomeninges and cerebrospinal fluid of both AD mice and AD patients. This finding underscores the relevance of the adaptive immune system, particularly T and B cells, in AD neuropathology. T-cell infiltration into the brain can influence amyloid clearance through chemokine signalling. However, chemokines play a critical role in AD by either promoting or suppressing disease progression. The infiltration of peripheral T and B cells into the brain parenchyma can exacerbate neuronal loss, yet it may also exert neuroprotective effects. Despite the presence of CD4+ and CD8+ T cells in postmortem brains of AD patients, debate continues about their role in AD brains, in terms of whether they are protective or detrimental. Understanding the complex role of chemokines in controlling innate and adaptive immune responses by modulating neuron–glia interactions (involving astrocytes and microglia) may provide novel therapeutic approaches for AD. Targeting chemokine signalling or treating with drugs that can prevent the recruitment of immune cells may be promising strategies for treating AD neuropathology. Therapies that prevent the overactivation of T cells in the brain could lead to protective strategies against AD. In fact, regulatory T cells (Tregs) could delay the onset of cognitive symptoms, because they suppress inflammation and slow the accumulation of Aβ plaques and p-Tau in the brain. Complementary strategies, such as photobiomodulation, nanoparticle, and T-cell-based approaches, could mitigate AD progression in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAdaptive ImmunityChemokinesNeuroinflammatory DiseasesHumansAnimalsDisease ProgressionBrainAmyloid beta-PeptidesT-Lymphocytes

Stichwörter der Autor:innen

Alzheimer’s disease and neurodegenerative diseasesCX3CR1/fractalkineCXCL0CXCR6T cellsTregadaptive immune systemamyloid-βchemokinesglial activationimmunobiologyimmunologyinflammationinnate immune systemmonocytes

Substanzen

ChemokinesAmyloid beta-Peptides

Autor:innen und Institutionen

  • Facultad de Farmacia, Departamento de Farmacología, Farmacognosia y Botánica, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.
  • Instituto Pluridisciplinar, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.
  • Grupo de Medicina Regenerativa, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
  • Functional Neuroanatomy Group, IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.
  • Department of Neurosciences, Medical Faculty, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
  • Laboratory of Molecular Cell Biomedicine, Department of Biology, Faculty of Medicine, University of the Balearic Islands, 07122 Palma de Mallorca, Spain.

ORCID-Profile: Xavier Busquets, Isabel Álvarez-Vicente, Ana Isabel Flores, Adolfo Toledano Gasca

Förderung

  • “Ramon and Cajal Research Program”, Spanish Ministry of Science, Innovation and Universities

Zitieren

APA

Merino, J. J., Rodríguez-Arellano, J. J., Busquets, X., Álvarez-Vicente, I., Cabaña-Muñoz, M. E., Flores, A. I., & Gasca, A. T. (2026). The Immune-Chemokine Axis in Alzheimer’s Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression. Biomolecules. https://doi.org/10.3390/biom16060855

Vancouver

Merino JJ, Rodríguez-Arellano JJ, Busquets X, Álvarez-Vicente I, Cabaña-Muñoz ME, Flores AI, et al. The Immune-Chemokine Axis in Alzheimer’s Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression. Biomolecules. 2026. doi:10.3390/biom16060855

BibTeX
@article{Merino2026,
  author = {Merino, José Joaquín and Rodríguez-Arellano, José Julio and Busquets, Xavier and Álvarez-Vicente, Isabel and Cabaña-Muñoz, María Eugenia and Flores, Ana Isabel and Gasca, Adolfo Toledano},
  title = {The Immune-Chemokine Axis in Alzheimer’s Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16060855}
}
Kostenlos starten →